Sarepta surges after FDA panel backs Duchenne gene therapy
Go back to Sarepta surges after FDA panel backs Duchenne gene therapy| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 20.52 -1.5 (6.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.02 | 52 Week High | $63.73 | |||
| Open | $22.02 | 52 Week Low | $8.00 | |||
| Day High | $22.02 | P/E | N/A | |||
| Day Low | $20.28 | EPS | $-5.69 | |||
| Volume | 2,204,294 | |||||
